Research progress on the application of biomimetic nanocarriers functionalized with erythrocyte membrane for atherosclerosis therapy
Author:
Affiliation:

Key Laboratory for Biorheological Science and Technology of Ministry of Education & State and Local Joint Engineering Laboratory for Vascular Implants & Bioengineering College of Chongqing University, Chongqing 400030, China)

Clc Number:

R363;R5

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    In recent years, the use of cell membrane-coated nanoparticles to develop biomimetic nanomedicines for atherosclerosis treatment has become a research hotspot. Among various cell membranes, due to the unique biological properties, red blood cells have been widely used as drug delivery. Erythrocyte membrane camouflaged biomimetic nanomedicines can not only prolong the circulation time and improve the biocompatibility in vivo, but also exhibit excellent passive targets through the enhanced permeability and retention effects of lesions for safe and efficient atherosclerosis therapy.Herein, this paper reviews erythrocyte membrane coating technology in the application of constructing the biomimetic nanomediciens in recent years, and focuses on its research applications in atherosclerosis therapy.

    Reference
    Related
    Cited by
Get Citation

CAO Yu, MOU Nianlian, ZHU Li, WANG Yi, WANG Guixue, WU Wei. Research progress on the application of biomimetic nanocarriers functionalized with erythrocyte membrane for atherosclerosis therapy[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2023,31(1):1-8.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:February 11,2022
  • Revised:May 06,2022
  • Online: December 26,2022
Article QR Code